541
Views
53
CrossRef citations to date
0
Altmetric
Review

Hepatitis B vaccine effectiveness in the face of global HBV genotype diversity

, , , &
Pages 1709-1715 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Kimia Kardani, Parya Basimi, Mehrshad Fekri & Azam Bolhassani. (2020) Antiviral therapy for the sexually transmitted viruses: recent updates on vaccine development. Expert Review of Clinical Pharmacology 13:9, pages 1001-1046.
Read now
Caroline Van Den Ende, Cinzia Marano, Ayla Van Ahee, Eveline M. Bunge & Laurence De Moerlooze. (2017) The immunogenicity and safety of GSK’s recombinant hepatitis B vaccine in adults: a systematic review of 30 years of experience. Expert Review of Vaccines 16:8, pages 811-832.
Read now
Tung-Hung Su & Jia-Horng Kao. (2015) Improving clinical outcomes of chronic hepatitis B virus infection. Expert Review of Gastroenterology & Hepatology 9:2, pages 141-154.
Read now
Sheikh Mohammad Fazle Akbar, Mamun Al-Mahtab & Md. Sakirul Islam Khan. (2013) Non-antigen-specific and antigen-specific immune therapies for chronic hepatitis B: evidences from laboratory benches and patient's bedsides. Expert Opinion on Biological Therapy 13:7, pages 1063-1074.
Read now

Articles from other publishers (49)

Nian Liu, Xiangyu Xiao, Ziqiang Zhang, Chun Mao, Mimi Wan & Jian Shen. (2023) Advances in Cancer Vaccine Research. ACS Biomaterials Science & Engineering 9:11, pages 5999-6023.
Crossref
Arturo Panduro, Sonia Roman, Saul Laguna-Meraz & Alexis Jose-Abrego. (2023) Hepatitis B Virus Genotype H: Epidemiological, Molecular, and Clinical Characteristics in Mexico. Viruses 15:11, pages 2186.
Crossref
Rayana Maryse Toyé, Carmen Luisa Loureiro, Rossana Celeste Jaspe, Fabien Zoulim, Flor Helene Pujol & Isabelle Chemin. (2023) The Hepatitis B Virus Genotypes E to J: The Overlooked Genotypes. Microorganisms 11:8, pages 1908.
Crossref
Lung-Yi Mak, Ian Beasley & Patrick T. F. Kennedy. (2022) Chronic Viral Hepatitis in Elite Athletes: Approaches to Risk Assessment, Prevention and Management. Sports Medicine - Open 8:1.
Crossref
Chen-Hsuan Wu, Wei-Cheng Huang, Chien-Hung Chen & Sheng-Nan Lu. (2022) Outcomes of hepatitis B immunoglobulin and hepatitis B vaccination in high-risk newborns born to HBeAg-positive mothers. Biomedical Journal 45:5, pages 798-805.
Crossref
Zachary M. Shaver, Motswedi Anderson, Lynnette Bhebhe, Kabo Baruti, Wonderful T. Choga, Julia Ngidi, Tshepiso Mbangiwa, Modiri Tau, Ditiro R. Setlhare, Pinkie Melamu, Bonolo B. Phinius, Rosemary Musonda, Madisa Mine, Sikhulile Moyo & Simani Gaseitsiwe. (2022) Decreased hepatitis B virus vaccine response among HIV-positive infants compared with HIV-negative infants in Botswana. AIDS 36:6, pages 755-762.
Crossref
Mais Mahmoud MohammedHassan Mohammad Naif. (2022) Poly(Lactide- co -Glycolide) Nanoparticle-Mediated Vaccine Delivery of Encapsulated Surface Antigen Protein of Hepatitis B Virus Elicits Effective Immune Response . Viral Immunology 35:2, pages 112-121.
Crossref
N. Ullah, I. Khan, M. A. Kakakhel, L. Xi, Y. Bai, B. S. Kalra, L. Guanlan, T. Kumar, M. Shah & C. Zhang. (2022) Serological prevalence of hepatitis B virus (HBV) in Mardan district, Khyber Pakhtunkhwa, Pakistan. Brazilian Journal of Biology 82.
Crossref
Luicer Anne Olubayo Ingasia, Constance Wose Kinge & Anna Kramvis. (2021) Genotype E: The neglected genotype of hepatitis B virus. World Journal of Hepatology 13:12, pages 1875-1891.
Crossref
Yakun Tian, Wei Hua, Yaxin Wu, Tong Zhang, Wen Wang, Hao Wu, Caiping Guo & Xiaojie Huang. (2021) Immune Response to Hepatitis B Virus Vaccine Among People Living With HIV: A Meta-Analysis. Frontiers in Immunology 12.
Crossref
N. A. Gavrilova, Yu. V. Olefir, V. A. Merkulov, V. P. Bondarev, E. M. Rychikhina & Yu. I. Obukhov. (2021) Vaccine interchangeability: problems and prospects. BIOpreparations. Prevention, Diagnosis, Treatment 21:3, pages 142-157.
Crossref
Sheikh Mohammad Fazle Akbar, Mamun Al Mahtab, Julio Cesar Aguilar, Md. Helal Uddin, Md. Sakirul Islam Khan, Osamu Yoshida, Eduardo Penton, Guillen Nieto Gerardo & Yoichi Hiasa. (2021) Exploring evidence-based innovative therapy for the treatment of chronic HBV infection: experimental and clinical. Exploration of Medicine.
Crossref
Praopilad Srisuwarn & Vasant Sumethkul. (2021) Kidney transplant from donors with hepatitis B: A challenging treatment option. World Journal of Hepatology 13:8, pages 853-867.
Crossref
Ashleigh Qama, Nicole Allard, Benjamin Cowie, Joshua S. Davis & Jane Davies. (2021) Hepatitis B in the Northern Territory: insights into the changing epidemiology of an ancient condition. Internal Medicine Journal 51:6, pages 910-922.
Crossref
Francisco Diaz-Mitoma, Vlad Popovic & Johanna N. Spaans. (2021) Assessment of immunogenicity and safety across two manufacturing lots of a 3-antigen hepatitis B vaccine, Sci-B-Vac®, compared with Engerix-B® in healthy Asian adults: A phase 3 randomized clinical trial. Vaccine 39:29, pages 3892-3899.
Crossref
Kojiro Michitaka, Atsushi Hiraoka, Tomoyuki Ninomiya, Naofumi Ohno, Takao Watanabe, Osamu Yoshida, Yoshio Tokumoto, Masanori Abe & Yoichi Hiasa. (2020) The Effect of the Hepatitis B Vaccine Derived from Genotype C on Infants Born to Mothers Infected with Genotype D. Internal Medicine 59:22, pages 2825-2830.
Crossref
Mulat Dagnew, Yihenew Million, Mucheye Gizachew, Setegn Eshetie, Gashaw Yitayew, Lakachew Asrade, Mulat Adefris, Feleke Moges & Moges Tiruneh. (2020) Hepatitis B and C Viruses’ Infection and Associated Factors among Pregnant Women Attending Antenatal Care in Hospitals in the Amhara National Regional State, Ethiopia. International Journal of Microbiology 2020, pages 1-11.
Crossref
Huiming Ye, Jing Teng, Zhiyuan Lin, Ye Wang & Xiaochun Fu. (2020) Analysis of HBsAg mutations in the 25 years after the implementation of the hepatitis B vaccination plan in China. Virus Genes 56:5, pages 546-556.
Crossref
Takako Inoue & Yasuhito Tanaka. (2020) Cross-Protection of Hepatitis B Vaccination among Different Genotypes. Vaccines 8:3, pages 456.
Crossref
Ngoc Phan, Helen Faddy, Robert Flower, Kirsten Spann & Eileen Roulis. (2020) In Silico Analysis of Genetic Diversity of Human Hepatitis B Virus in Southeast Asia, Australia and New Zealand. Viruses 12:4, pages 427.
Crossref
Federico A. Di Lello, Jorgelina Blejer, Adriana Alter, Sonia Bartoli, Fabiana Vargas, Rosángela Ruiz, Claudio Galli, Sebastián Blanco, Sandra Gallego, Roberto Fernández, Alfredo P. Martínez & Diego M. Flichman. (2020) Hepatitis B surface antibodies seroprevalence among people born before and after implementation of universal HBV vaccination. Vaccine 38:12, pages 2678-2682.
Crossref
Soie Chung, Eun Youn Roh, Boram Park, Yunhwan Lee, Sue Shin, Jong Hyun Yoon & Eun Young Song. (2019) GWAS identifying HLA‐DPB1 gene variants associated with responsiveness to hepatitis B virus vaccination in Koreans: Independent association of HLA‐DPB1*04:02 possessing rs1042169 G ‐ rs9277355 C ‐ rs9277356 A . Journal of Viral Hepatitis 26:11, pages 1318-1329.
Crossref
Alexis Jose-Abrego. (2019) Some considerations about HBV vaccination among HIV patients from Latin America and the Caribbean. Annals of Hepatology 18:5, pages 656-657.
Crossref
María J. Limeres, Evangelina R. Gomez, Diego G. Noseda, Carolina S. Cerrudo, Pablo D. Ghiringhelli, Alejandro D. Nusblat & María L. Cuestas. (2019) Impact of hepatitis B virus genotype F on in vitro diagnosis: detection efficiency of HBsAg from Amerindian subgenotypes F1b and F4. Archives of Virology 164:9, pages 2297-2307.
Crossref
Yuji Hoshi, Takashi Hasegawa, Naoji Yamagishi, Masashi Mizokami, Masaya Sugiyama, Keiji Matsubayashi, Shigeharu Uchida, Tadashi Nagai & Masahiro Satake. (2019) Optimal titer of anti‐HBs in blood components derived from donors with anti‐HBc. Transfusion 59:8, pages 2602-2611.
Crossref
Federico A. Di Lello, Ezequiel Ridruejo, Alfredo P. Martínez, Paula S. Pérez, Rodolfo H. Campos & Diego M. Flichman. (2019) Molecular epidemiology of hepatitis B virus mutants associated with vaccine escape, drug resistance and diagnosis failure. Journal of Viral Hepatitis 26:5, pages 552-560.
Crossref
Nao Nishida, Masaya Sugiyama, Hiromi Sawai, Sohji Nishina, Aiko Sakai, Jun Ohashi, Seik‐Soon Khor, Keisuke Kakisaka, Takayo Tsuchiura, Keisuke Hino, Ryo Sumazaki, Yasuhiro Takikawa, Kazumoto Murata, Tatsuo Kanda, Osamu Yokosuka, Katsushi Tokunaga & Masashi Mizokami. (2018) Key HLA‐DRB1‐DQB1 haplotypes and role of the BTNL2 gene for response to a hepatitis B vaccine. Hepatology 68:3, pages 848-858.
Crossref
Kate WhitfordBette LiuJoanne MicallefJ Kevin YinKristine MacartneyPierre Van DammeJohn M Kaldor. (2018) Long-term impact of infant immunization on hepatitis B prevalence: a systematic review and meta-analysis. Bulletin of the World Health Organization 96:7, pages 484-497.
Crossref
Najeeb Ullah Khan, Ali Zalan, Arnolfo Petruzziello, Iftikhar ud din, Fazle Haq & Yousaf Hayat. (2018) Determining the Actual Prevalence of Hepatitis B in Khyber Pakhtunkhwa-Pakistan: A Meta-Analysis. The Open Virology Journal 12:1, pages 33-41.
Crossref
Olympia E. Anastasiou, Marek Widera, Johannes Korth, Helenie Kefalakes, Antonios Katsounas, Gudrun Hilgard, Guido Gerken, Ali Canbay, Sandra Ciesek & Jens Verheyen. (2018) Clinical patterns associated with the concurrent detection of anti-HBs and HBV DNA. Journal of Medical Virology 90:2, pages 282-290.
Crossref
Ji-Hong Cheng, Wen-Chun Liu, Ting-Tsung Chang, Sun-Yuan Hsieh & Vincent S. Tseng. (2017) Detecting exact breakpoints of deletions with diversity in hepatitis B viral genomic DNA from next-generation sequencing data. Methods 129, pages 24-32.
Crossref
Wen-Chun Liu, I-Chin Wu, Yen-Chien Lee, Chih-Peng Lin, Ji-Hong Cheng, Yih-Jyh Lin, Chia-Jui Yen, Pin-Nan Cheng, Pei-Fu Li, Yi-Ting Cheng, Pei-Wen Cheng, Koun-Tem Sun, Shu-Ling Yan, Jia-Jhen Lin, Jui-Chu Yang, Kung-Chao Chang, Cheng-Hsun Ho, Vincent S Tseng, Bill Chia-Han Chang, Jaw-Ching Wu & Ting-Tsung Chang. (2017) Hepatocellular carcinoma-associated single-nucleotide variants and deletions identified by the use of genome-wide high-throughput analysis of hepatitis B virus. The Journal of Pathology 243:2, pages 176-192.
Crossref
Masaki Kato, Susumu Hamada-Tsutsumi, Chiaki Okuse, Aiko Sakai, Nobuyuki Matsumoto, Masaaki Sato, Toshiyuki Sato, Mitsumi Arito, Kazuki Omoteyama, Naoya Suematsu, Kazuki Okamoto, Takanobu Kato, Fumio Itoh, Ryo Sumazaki, Yasuhito Tanaka, Hiroshi Yotsuyanagi, Tomohiro Kato & Manae Suzuki Kurokawa. (2017) Effects of vaccine-acquired polyclonal anti-HBs antibodies on the prevention of HBV infection of non-vaccine genotypes. Journal of Gastroenterology 52:9, pages 1051-1063.
Crossref
V. P. Chulanov, T. A. Semenenko, I. V. Karandashova, S. V. Komarova, D. S. Kostyushev, A. P. Suslov & E. V. Volchkova. (2017) Modern View on the Problem of Choosing a Vaccine against Hepatitis B. Epidemiology and Vaccine Prevention 16:4, pages 65-72.
Crossref
Forough Golsaz-Shirazi, Mohammad Mehdi Amiri, Samira Farid, Motahareh Bahadori, Felix Bohne, Sebastian Altstetter, Lisa Wolff, Tohid Kazemi, Jalal Khoshnoodi, Mohammad Hojjat-Farsangi, Michael Chudy, Mahmood Jeddi-Tehrani, Ulrike Protzer & Fazel Shokri. (2017) Construction of a hepatitis B virus neutralizing chimeric monoclonal antibody recognizing escape mutants of the viral surface antigen (HBsAg). Antiviral Research 144, pages 153-163.
Crossref
Xin Ji, Mohammad Zafrullah, Nicholas Wiese, Tonya Hayden-Mixon, Joseph C. Forbi, Chong-Gee Teo & Michael A. Purdy. (2017) Permissive, in vitro replication of hepatitis B virus genotype E. Journal of Virological Methods 243, pages 20-24.
Crossref
Selma A. de Gomes, Natalia M. Araujo, Diego Flichman, Rodolfo Campos & Arturo Panduro. 2017. Human Virology in Latin America. Human Virology in Latin America 309 331 .
Fassil Shiferaw, Mekitew Letebo & Abate Bane. (2016) Chronic viral hepatitis: policy, regulation, and strategies for its control and elimination in Ethiopia. BMC Public Health 16:1.
Crossref
Lemonica Koumbi, Teresa Pollicino, Giovanni Raimondo, Dimitrios Stampoulis, Salim Khakoo & Peter Karayiannis. (2016) Hepatitis B virus basal core promoter mutations show lower replication fitness associated with cccDNA acetylation status. Virus Research 220, pages 150-160.
Crossref
Sheikh MF Akbar, Mamun Al-Mahtab, Sakirul I Khan, Ananta Shrestha, Shahina Tabassum & Yoichi Hiasa. (2016) Current trends in hepatitis B vaccination. Future Virology 11:5, pages 369-378.
Crossref
Olivier Van Der Meeren, Ulrich Behre & Priya Crasta. (2016) Immunity to hepatitis B persists in adolescents 15–16 years of age vaccinated in infancy with three doses of hepatitis B vaccine. Vaccine 34:24, pages 2745-2749.
Crossref
B.A.H. Al- Nabehi, H. Al- Shamahy, W.S.E. Saeed, A.M. Musa, A.M. El Hassan & E.A.G. Khalil. (2015) Sero-Molecular Epidemiology and Risk Factors of Viral Hepatitis in Urban Yemen. International Journal of Virology 11:3, pages 133-138.
Crossref
Kazuto Tajiri & Yukihiro Shimizu. (2015) Unsolved problems and future perspectives of hepatitis B virus vaccination. World Journal of Gastroenterology 21:23, pages 7074-7083.
Crossref
Susumu Hamada-Tsutsumi, Etsuko Iio, Tsunamasa Watanabe, Shuko Murakami, Masanori Isogawa, Sayuki Iijima, Takako Inoue, Kayoko Matsunami, Kazuto Tajiri, Tatsuhiko Ozawa, Hiroyuki Kishi, Atsushi Muraguchi, Takashi Joh & Yasuhito Tanaka. (2015) Validation of Cross-Genotype Neutralization by Hepatitis B Virus-Specific Monoclonal Antibodies by In Vitro and In Vivo Infection. PLOS ONE 10:2, pages e0118062.
Crossref
Teresa Pollicino. (2015) Role natural killer group 2D-ligand interactions in hepatitis B infection. World Journal of Hepatology 7:6, pages 819.
Crossref
Haruki Komatsu, Kentaro Iwasawa, Ayano Inui, Tomoyuki Tsunoda, Shuichiro Umetsu, Tsuyoshi Sogo & Tomoo Fujisawa. (2015) Effectiveness of genotype C-derived hepatitis B vaccine in preventing perinatal transmission in children born to hepatitis B virus carrier mothers infected with genotype A. Kanzo 56:12, pages 675-677.
Crossref
Said Ali Al Baqlani, Bui Tien Sy, Boris A. Ratsch, Khalid Al Naamani, Salah Al Awaidy, Suleiman Al Busaidy, Georg Pauli & C.-Thomas Bock. (2014) Molecular Epidemiology and Genotyping of Hepatitis B Virus of HBsAg-Positive Patients in Oman. PLoS ONE 9:5, pages e97759.
Crossref
N Obeng-Adjei, N A Hutnick, J Yan, J S Chu, D J F Myles, M P Morrow, N Y Sardesai & D B Weiner. (2013) DNA vaccine cocktail expressing genotype A and C HBV surface and consensus core antigens generates robust cytotoxic and antibody responses in mice and Rhesus macaques. Cancer Gene Therapy 20:12, pages 652-662.
Crossref
Maryam Yazdanian, Arash Memarnejadian, Mehdi Mahdavi, Seyed Mehdi Sadat, Fatemeh Motevali, Rouhollah Vahabpour, Hossein Khanahmad, Seyed Davar Siadat, Mohammad Reza Aghasadeghi & Farzin Roohvand. (2013) Immunization of Mice by BCG Formulated HCV Core Protein Elicited Higher Th1-Oriented Responses Compared to Pluronic-F127 Copolymer. Hepatitis Monthly 13:10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.